Dr. Abuchowski was the originator of PEGylation technology, now the most widely used protein drug delivery system in the world. He was the founder and past Chairman and CEO of Enzon, Inc., the biopharmaceutical company that commercialized PEGylation technology.
During his 13 years at Enzon, Dr. Abuchowski successfully commercialized PEGylation by gaining FDA approval for three protein-based drugs. Dr. Abuchowski was instrumental in helping Enzon mature from a developmental stage company to a fully integrated publicly traded biopharmaceutical company.
Dr. Abuchowski holds a B.S. and Ph.D. in Biochemistry from Rutgers University. He is an internationally recognized authority on drug delivery and has published numerous scientific papers and several book chapters on therapeutic products. In 1994, Dr. Abuchowski founded the Biotechnology Council of New Jersey and served as its first Chairman.